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Objective. To explore risk factors for macro- and microvascular complications in a nationally representative sample of adults aged
50 years and over with type 2 diabetes in Ireland. Methods. Data from the first wave of The Irish Longitudinal Study on Ageing
(TILDA) (2009–2011) was used in cross-sectional analysis. The presence of doctor diagnosis of diabetes, risk factors, and macro-
andmicrovascular complicationswere determined by self-report.Gender-specific differences in risk factor prevalencewere assessed
with the chi-squared test. Binomial regression analysis was conducted to explore independent associations between established risk
factors and diabetes-related complications. Results. Among 8175 respondents, 655 were classified as having type 2 diabetes. Older
age, being male, a history of smoking, a lower level of physical activity, and a diagnosis of high cholesterol were independent
predictors of macrovascular complications. Diabetes diagnosis of 10 or more years, a history of smoking, and a diagnosis of
hypertension were associated with an increased risk of microvascular complications. Older age, third-level education, and a high
level of physical activity were protective factors (𝑝 < 0.05). Conclusions. Early intervention to target modifiable risk factors is
urgently needed to reduce diabetes-related morbidity in the older population in Ireland.
1. Introduction
Over the past two decades, the global burden of diabetes
has increased significantly [1–3]. Between 1998 and 2015, the
prevalence of diabetes increased from 2.2% to 5.2% among
the adult population in Ireland [4]. In 2010, diabetes was the
ninth leading cause of mortality [1] and the 14th largest cause
of disability adjusted life years (DALYs) [2] worldwide. The
economic cost of diabetes is also high and will continue to
rise; approximately 12%of theworld’s total health expenditure
was spent on diabetes in 2010 [5]. The vast majority of
this burden is attributable to the macrovascular (myocar-
dial infarction, congestive cardiac failure, and cerebrovas-
cular accident) and microvascular (diabetic neuropathy,
retinopathy, and nephropathy) complications of diabetes [3].
The Cost of Diabetes in Europe-Type II study reported that
72% of people had at least one diabetes-related complication
[6]. In Ireland, the prevalence of macro- and microvascular
complications among adults aged 50 years and over with type
2 diabetes is 15% and 26%, respectively [7].
Compared to the general population, individuals with
type 2 diabetes are at an increased risk of developing
cardiovascular disease (CVD) [8, 9]. Type 2 diabetes is
also a significant cause of blindness in adults, nontraumatic
lower limb amputations, and end-stage renal disease resulting
in transplantation and dialysis [3]. We reported that the
risk of visual impairment, in adults aged 50–69 years, is
approximately four times higher in the population with
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diabetes compared to those without diabetes [10]. Buckley
et al. [11] found that the risk of an individual with diabetes
undergoing lower-leg amputation was 22 times that of an
individual without diabetes.
Time-related variables, such as age and longer diabetes
duration, are associated with the onset of diabetes-related
complications [12]. Established risk factors for CVD such as
hypertension, high cholesterol, and smoking further increase
the likelihood of developing both macro- and microvas-
cular complications [13]. Socioeconomic status (SES) has
also been identified as a predictor of microvascular com-
plications. Lower educational attainment is considered to
influence the development of such complications through
health behaviours, access to care, and processes of diabetes
care [14–17].While the national prevalence of diagnosed type
2 diabetes and related complications has been established
among the older population in Ireland [7], evidence on the
individual level risk factors for macro- and microvascular
complications is lacking. Identification and treatment of risk
factors can delay or prevent the development of diabetes-
related complications [3].Therefore, the purpose of this paper
is to identify the determinants of macro- and microvascular
complications among adults aged 50 years and over with
diagnosed type 2 diabetes.
2. Material and Methods
2.1. Data Source. Data from the first wave (2009–2011)
of The Irish Longitudinal Study on Ageing (TILDA), a
population-based prospective cohort study of community-
dwelling adults aged 50 and over in Ireland, were used in
this cross-sectional analysis [18]. A nationally representative
sample was selected using the RANSAM sampling technique
from a listing of all residential addresses in Ireland (the
Irish Geodirectory) [19]. A total of 8175 adults aged 50 years
and over completed a computer-assisted personal interview
(CAPI), representing a household response rate of 62%.
The CAPI was administered by trained social interviewers
in the participants’ homes. This recorded detailed informa-
tion on health, social, and economic circumstances. During
the CAPI, participants reported their medication use and
interviewers noted the correct name from the medication
packaging. Medications were assignedWorld Health Organi-
zation Anatomic Therapeutic Chemical (ATC) classification
codes [20]. Ethical approval was obtained from the Faculty
of Health Sciences Research Ethics Committee of Trinity
College Dublin. Written informed consent was provided by
all respondents before participation [18].
2.2. Type 2 Diabetes Classification. Methods to classify diag-
nosed type 2 diabetes andmacro- andmicrovascular compli-
cations have been reported in detail elsewhere [7]. In brief,
individuals were classified as having diagnosed diabetes if
they self-reported a previous doctor diagnosis or if they
reported the use of insulin or oral hypoglycaemic agents
during the CAPI. Age at diabetes diagnosis (years) was
established by self-report. Anyone aged less than 40 years at
diagnosis and injecting insulin but not on oral hypoglycaemic
agents was classified as having type 1 diabetes; all others were
classified as having diagnosed type 2 diabetes [21].
2.3. Macrovascular and Microvascular Complications. All
TILDA participants were asked the question “Has a doctor
ever told you that you have any of the conditions on this card?”
Heart attack (myocardial infarction), heart failure (congestive
cardiac failure), stroke (cerebrovascular accident), and mini
stroke (transient ischemic attack (TIA)) were included in
the list and were defined as macrovascular complications.
Participants who reported a doctor diagnosis of diabetes were
asked the question “Has a doctor ever told you that you have
any of the following conditions related to your diabetes?” The
conditions listedwere leg ulcer, protein in urine (proteinuria),
lack of feeling and tingling pain in legs and feet due to
nerve damage (diabetic neuropathy), damage to the back of
your eye (diabetic retinopathy), or damage to your kidneys
(diabetic nephropathy); these were defined as microvascular
complications [21]. Macro- and microvascular complications
were collapsed into dichotomous variables, to indicate the
presence or absence of at least one complication.
2.4. Covariates. Sociodemographic, behavioural, and med-
ical history variables were recorded in the CAPI including
sex, age (50–64 years, 65–74 years, and 75+ years), loca-
tion of household (capital city (Dublin), another town/city,
and rural), educational attainment (primary-level or none,
secondary-level, and third-level or higher), and medical care
cover (means-tested public health insurance scheme for those
on low incomes, supplementary private health insurance,
dual cover (both state-assisted cover and private insurance),
and no additional cover for healthcare). Smoking status was
classified as having ever smoked (current and former smoker)
and never smoked (nonsmoker). Physical activity (low, mod-
erate, and high) was self-reported using the short version of
the International Physical ActivityQuestionnaire (IPAQ) and
categorised using the IPAQ scoring protocol [22]. Duration
of diabetes diagnosis was calculated by subtracting age at
diagnosis from age (years) at interview and was subsequently
categorised (0–4 years, 5–9 years, and ≥10 years). The use of
diabetes medication (oral hypoglycaemic agents, insulin, or
none) was reclassified as diet alone, oral agents alone, insulin
alone, or oral agents and insulin. A previous doctor diagnosis
of hypertension or high cholesterol was ascertained by self-
report.
2.5. Statistical Analysis. Analysis was carried out in Stata
version 13 for Windows (StataCorp, College Station, TX)
using the survey function (svy). Inverse probability weights
were applied to all analyses to provide population estimates.
Weights were calculated according to the distribution ofmar-
ital status, educational attainment, and geographic location
using Irish census data from the period of 2006–2010 and to
the distribution of age and sex using Irish census data from
2011 [23].
Descriptive statistics were used to summarise charac-
teristics of the population with diagnosed type 2 diabetes
and were stratified by gender. Gender-specific differences
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in categorical variables were analysed using Pearson’s chi-
square test.Themean and standard deviationwere reported if
continuous data conformed to normality and Student’s 𝑡-test
was conducted to compare means. If data were skewed, the
median with associated lower and upper quartile values was
reported and the Mann-Whitney test was utilised.
Associations between risk factors and diabetes-related
complications were examined using a log-binomial regres-
sion. Risk ratios (RR) and 95%CIwere generated as ameasure
of association. Risk factors served as independent variables
andwere chosen on the basis of previous literature [12, 14, 24–
35] or if significant associations were observed in univariate
analysis. A forward blockwise entry method was used with
independent variables which were entered into the regression
model in three blocks: (1) sociodemographic variables (age,
sex, and education attainment) and duration of diabetes
diagnosis, (2) behavioural factors (ever smoking and level of
physical activity), and (3)medical history variables (diagnosis
of hypertension, high cholesterol). Collinearity was assessed
by the variance inflation factor (VIF); a VIF of >10 indicated
multicollinearity. Statistical significance was defined as 𝑝 <
0.05.
3. Results
Of the 8175 participants in TILDA, 634 participants reported
a previous doctor diagnosis of diabetes and 38 participants
did not report a diagnosis of diabetes but were classified as
having diabetes by the use of oral hypoglycaemic agents or
insulin.Of these, 17 peoplewere classified as having type 1 dia-
betes and were excluded from the present analysis. Of the 655
people with type 2 diabetes, 57.7% were male and the mean
agewas 66.6 (SD= 8.8) years. Table 1 shows the characteristics
of the population with type 2 diabetes, stratified by gender.
Approximately half of the participants were diagnosed with
diabetes between the ages of 50–69 years (51.8% [47.6%
to 55.9%]). The median time since diabetes diagnosis was
5.3 years (IQR 2 to 11 years). Approximately half the study
sample had completed secondary- or third-level education
(51.1% [46.9% to 55.4%]). In terms of disease management,
17.5% (14.8% to 20.6%) of the participants managed type 2
diabetes with diet alone, 74.2% (70.6% to 77.5%) reported the
use of oral hypoglycaemic agents, and 7.5% (5.6% to 10.0%)
reported using both oral hypoglycaemic agents and insulin.
The prevalence of cardiovascular risk factors was high among
participants; 18.8% (15.8% to 22.3%) of the participants were
current smokers, 62.5% (58.1% to 66.6%) reported a previous
doctor diagnosis of hypertension, and 51.7% (47.5% to 55.9)
reported a previous doctor diagnosis of high cholesterol.
Current smoking was higher among females compared to
males (20.6% [15.5% to 26.5%] versus 17.5% [13.9% to 26.5%])
and a higher proportion of males reported higher levels of
physical activity (27.5% [23.2% to 32.3%] versus 13.7% [9.6%
to 19.2%]). Fifteen percent (15.1% [12.3% to 18.4%]) of the
participants reported a previous doctor diagnosis of at least
one macrovascular complication and 26% (25.5% to 29.9%)
of the participants reported a previous doctor diagnosis of at
least one microvascular complication.
3.1. Factors Associated with Diabetes-Related Complications.
Table 2 presents the results from the binomial regression
analyses, where previous diagnosis of at least one macrovas-
cular complication served as the dependant variable.The risk
of a macrovascular complication was higher among older
participants (RR 1.6 [1.1 to 2.5] in 65 to 74 years; RR 2.0 [1.2
to 3.2] in 75 years or over versus 50 to 64 years). Female
participants were less likely to report a previous diagnosis of
a macrovascular complication relative to males (RR 0.6 [0.4–
0.8]). Finally, individuals classified as having ever smokedhad
a 60% increase in the risk of a macrovascular complication
compared to those who never smoked (RR 1.6 [1.1 to 2.6]).
Table 3 presents the results from the binomial regression
analyses, with previous diagnosis of at least one microvas-
cular complication as the dependant variable. There was no
evidence to suggest that the risk of microvascular compli-
cations was different in participants diagnosed for less than
four years compared to those diagnosed for a period between
five and nine years (RR 1.1 [0.8 to 1.7]), whereas participants
with type 2 diabetes for 10 or more years were approximately
twice as likely to have reported a microvascular complication
compared to those who had been diagnosed for less than
four years (RR 1.9 [1.4 to 2.5]). Participants who had ever
smokedwere almost one and a half timesmore likely to report
a doctor diagnosis of a microvascular complication relative
to those who never smoked (RR 1.4 [1.1 to 2.0]). While the
risk of a microvascular complication did not differ between
those with a secondary-level education compared to those
with primary-level or less education (RR 0.9 [0.6 to 1.2]),
the risk was significantly decreased in participants with a
third-level education (RR 0.6 [0.4 to 0.9]) compared to those
with primary-level or less education. The risk of a microvas-
cular complication did not differ between participants who
reported a moderate level of physical activity compared to
those with low level of activity (RR 0.8 [0.6 to 1.1]). However,
participants from the highest physical activity category were
50% less likely to report amicrovascular complication (RR 0.5
[0.3–0.8]) compared to participants with low level of activity.
Participants diagnosedwith hypertensionwere one and a half
times more likely to have reported a previous diagnosis of at
least one microvascular complication relative to participants
who had not reported a previous diagnosis (RR 1.5 [1.1–2.1]).
Collinearity was not found between variables (VIF ≤ 2).
4. Discussion
To our knowledge, this is the first study to identify indi-
vidual level risk factors associated with macrovascular and
microvascular complications among people with type 2
diabetes in Ireland using nationally representative data. Older
age, having ever smoked, and a previous doctor diagnosis
of high cholesterol were independently associated with an
increased risk of macrovascular complications, while being
female and high levels of physical activity demonstrated a
protective effect. Longer duration since diagnosis, having ever
smoked, and a previous doctor diagnosis of hypertension
were associated with an increased risk of microvascular com-
plicationswhereas achieving a third-level or higher education
4 Journal of Diabetes Research
Table 1: Descriptive characteristics of the first-wave TILDA sample aged ≥50 years with diagnosed type 2 diabetes, 2009–2011.
Variable
Type 2 diabetes (total 𝑛 = 655)
Male Female
𝑝
Total
𝑛 (%) 𝑛 (%) % (95% CI)
Age
Years (mean, sd.) 66.6 (9.7) 68.6 (10.4) 67.4 (10.1)
Location
Dublin 92 (25.5) 77 (31.5) 0.17 27.9 (23.1, 33.4)
Another city 113 (30.0) 84 (34.1) 31.7 (26.9, 36.9)
Rural 182 (44.5) 105 (35.3) 40.3 (35.2, 45.7)
Educational attainment
Primary/none 163 (48.6) 116 (54.7) 0.12 51.1 (46.9, 55.4)
Secondary 137 (37.1) 103 (36.1) 36.7 (32.9, 40.7)
Third-level/higher 89 (14.3) 47 (9.2) 12.2 (10.1, 14.6)
Medical cover
State-assisted 163 (43.9) 139 (57.8) <0.01 49.7 (45.4, 53.9)
Private insurance 111 (27.6) 60 (17.9) 23.6 (20.3, 27.2)
Dual cover 86 (19.9) 51 (18.7) 19.4 (16.2, 23.0)
No additional cover 30 (8.5) 16 (5.6) 7.3 (5.3, 10.1)
Smoking
Never 114 (29.9) 120 (44.0) <0.001 35.8 (31.8, 39.9)
Past 210 (52.7) 94 (35.4) 45.5 (41.2, 49.9)
Current 66 (17.5) 52 (20.1) 18.8 (15.8, 22.3)
Physical activity
Low 140 (36.8) 143 (56.5) <0.001 45.0 (40.8, 49.2)
Moderate 137 (35.7) 77 (29.8) 33.3 (29.5, 37.2)
High 109 (27.5) 43 (13.7) 21.8 (18.5, 25.5)
Age of diagnosis
<50 years 54 (16.4) 47 (16.8) 0.04 16.6 (13.7, 19.8)
50–69 years 196 (55.9) 125 (46.2) 51.8 (47.6, 55.9)
70+ years 112 (27.7) 84 (36.9) 31.6 (27.8, 35.7)
Duration of DM diagnosis
Years (median, IQR) 5.0 (1.5, 12) 5.5 (2.5, 15) 0.5 5.3 (2, 11)
DM treatment
Diet 64 (16.7) 53 (18.3) 0.9 17.5 (14.8, 20.6)
Oral meds 293 (74.7) 190 (73.9) 74.2 (70.6, 77.5)
Insulin 2 (1.0) 4 (0.8) 0.8 (0.3, 1.8)
Both 31 (8.2) 19 (6.5) 7.5 (5.6, 10.0)
Other medication
Hypertension 221 (58.4) 161 (60.0) 0.6 59.1 (55.4, 63.9)
High cholesterol 164 (43.4) 130 (46.5) 0.4 44.7 (40.4, 48.7)
Flu shot 286 (74.3) 212 (78.5) 0.2 76.1 (72.4, 79.5)
Doctor diagnosed
Hypertension 236 (61.2) 170 (63.8) 0.9 62.5 (58.1, 66.6)
High cholesterol 192 (50.0) 149 (54.2) 0.9 51.7 (47.5, 55.9)
DM complications
Macro 73 (17.8) 28 (11.4) 0.04 15.1 (12.3, 18.4)
Micro 89 (25.2) 67 (26.8) 0.7 26.0 (22.5, 29.9)
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Table 2: Multivariate binomial regression models exploring independent associations between macrovascular complications and predictor
variables∗.
Predictor Model 1
† Model 2 Model 3§
RR (95% CI) p RR (95% CI) p RR (95% CI) p
Age
50–64 years 1 1 1
65–74 years 1.6 (1.0, 2.5) 0.05 1.5 (0.9, 2.4) 0.07 1.6 (1.1, 2.5) 0.04
75+ years 2.0 (1.3, 3.3) 0.003 1.8 (1.1, 4.1) 0.01 2.0 (1.2, 3.2) 0.005
Gender
Male 1 1 1
Female 0.6 (04, 0.9) 0.007 0.6 (0.4, 0.9) 0.009 0.6 (0.4, 0.8) 0.005
Education
Primary/less 1 1 1
Secondary 0.9 (0.6, 1.3) 0.5 0.9 (0.6, 1.4) 0.5 0.9 (0.6, 1.3) 0.6
Third/higher 1.1 (0.7, 1.7) 0.7 1.2 (0.7, 1.8) 0.5 1.1 (0.7, 1.7) 0.7
Duration of diagnosis
0–4 years 1 1 1
5–9 years 1.0 (0.6, 1.7) 0.9 0.9 (0.6, 1.6) 0.9 1.0 (0.6, 1.7) 0.9
10+ years 1.2 (0.8, 1.8) 0.4 1.1 (0.7, 1.6) 0.7 1.1 (0.8, 1.7) 0.5
Ever smoked
No 1 1
Yes 1.7 (1.1, 2.7) 0.02 1.6 (1.1, 2.6) 0.04
Physical activity
Low 1 1
Medium 0.8 (0.6, 1.2) 0.3 0.9 (0.6, 1.2) 0.5
High 0.5 (0.3, 0.9) 0.01 0.5 (0.3, 0.9) 0.03
Previous hypertension
No 1
Yes 1.1 (0.8, 1.7) 0.5
Previous high cholesterol
No 1
Yes 1.7 (1.1, 2.5) 0.008
∗Indicating report of at least one macrovascular complication (heart attack, congestive heart failure, stroke, or TIA).
†Variables entered in Model 1: age, sex, education, and years since diagnosis.
Variables entered in Model 2: age, sex, education, years since diagnosis, smoking status, and physical activity.
§Variables entered inModel 3: age, sex, education, years since diagnosis, smoking status, physical activity, doctor diagnosed hypertension, and doctor diagnosed
high cholesterol.
and high levels of physical activity demonstrated a protective
effect.
Consistent with existing research [28, 29], established risk
factors for CVD [28, 29] and being male [28, 36] were found
to be independent predictors of at least one macrovascular
complication. The United Kingdom Prospective Diabetes
Study (UKPDS) reported that the risk of myocardial infarc-
tion and stroke were higher in older participants, smokers,
and those with high cholesterol [28, 29]. Prospective studies
have also identified hypertension [28–30, 32] as a risk factor
for the development of macrovascular complications among
individuals with type 2 diabetes; however, our study failed
to demonstrate a significant association. Our findings are
not atypical of existing research in this area; the diversity of
results has been discussed previously [28–30, 37]. Evidence
demonstrating an association between duration of diabetes
diagnosis andmacrovascular complications is also equivocal.
Some studies are in accordance with our findings [37]
whereas others have reported the opposite [12, 29]. Similar
to the present study, Fox et al. [37] failed to demonstrate
duration of diabetes as an independent predictor of com-
bined nonfatal macrovascular events (myocardial infarction,
stroke, congestive heart failure, and angina) [37], whereas
baseline data from the ADVANCE trial [12] demonstrated
that diabetes duration was an independent predictor of
nonfatal myocardial infarction and nonfatal stroke among
11,140 individuals with type 2 diabetes aged 55 years and older.
Unlike the previous study [12], we were unable to conduct
complication-specific analysis due to the small number of
reported events.
Consistent with previous research [12, 24–26, 33, 35],
longer duration since diabetes diagnosis was independently
associated with microvascular complications. Diabetes dura-
tion reflects total glycaemic control and risk factor exposure
6 Journal of Diabetes Research
Table 3: Multivariate binomial regression models exploring independent associations between microvascular complications and predictor
variables∗.
Predictor Model 1
† Model 2 Model 3§
RR (95% CI) p RR (95% CI) p RR (95% CI) p
Age
50–64 years 1 1 1
65–74 years 0.8 (0.6, 1.2) 0.4 0.9 (0.7, 1.2) 0.4 0.9 (0.7, 1.1) 0.3
75+ years 0.7 (0.5, 1.1) 0.1 0.7 (0.5, 0.9) 0.02 0.6 (0.5, 0.9) 0.01
Gender
Male 1 1 1
Female 1.0 (0.8, 1.4) 0.9 1.1 (0.7, 1.3) 0.8 1.0 (0.8, 1.3) 0.9
Education
Primary/less 1 1 1
Secondary 0.9 (0.7, 1.2) 0.4 0.9 (0.7, 1.2) 0.5 0.9 (0.7, 1.2) 0.5
Third/higher 0.6 (0.4, 0.8) 0.007 0.5 (0.4, 0.9) 0.02 0.6 (0.4, 0.9) 0.02
Duration of diagnosis
0–4 years 1 1 1
5–9 years 1.2 (0.8, 1.8) 0.3 1.1 (0.8, 1.6) 0.5 1.1 (0.8, 1.7) 0.5
10+ years 2.0 (1.5, 2.7) 0.000 1.8 (1.4, 2.5) 0.000 1.9 (1.4, 2.5) 0.000
Ever smoked
No 1 1
Yes 1.4 (1.1, 2.0) 0.03 1.4 (1.1, 2.0) 0.02
Physical activity
Low 1 1
Medium 0.7 (0.6, 1.0) 0.1 0.8 (0.6, 1.1) 0.1
High 0.5 (0.3, 0.7) 0.001 0.5 (0.3, 0.8) 0.003
Hypertension
No 1
Yes 1.5 (1.1, 2.1) 0.006
High cholesterol
No 1
Yes 1.0 (0.8, 1.3) 0.9
∗Indicating report of at least one microvascular complication (leg ulcer, protein in urine, neuropathy, retinopathy, or damage to kidneys).
†Variables entered in Model 1: age, sex, education, and years since diagnosis.
Variables entered in Model 2: age, sex, education, years since diagnosis, smoking status, and physical activity.
§Variables entered inModel 3: age, sex, education, years since diagnosis, smoking status, physical activity, doctor diagnosed hypertension, and doctor diagnosed
high cholesterol.
over time [38]. Likewise, both smoking and hypertension
have been identified as prominent risk factors in the devel-
opment of neuropathy, retinopathy, and nephropathy [24–
26, 30, 31, 39, 40]. Similar to previous findings [14, 24, 35,
41–43], higher educational attainment was associated with
a lower likelihood of microvascular complications in the
present study. Education is a universal indicator of SES and is
commonly used in cardiovascular epidemiology as it usually
remains constant after early childhood and is less likely
to be influenced by social changes or illness in adulthood
[44]. Lower educational attainment has been associated with
poorer disease management, lower rates of physical activity,
fewer ophthalmologic visits, and fewer foot examinations
[14]. Earlier detection by systematic screening can prevent
or delay the development of diabetes-related complications.
Reductions in leg amputation rates have been achieved in the
UK following changes to the structure of foot care for those
with diabetes [45, 46].
In the present study, the risk of microvascular compli-
cations was lower in participants who reported a high level
of physical activity compared to the lowest physical activity
group. This protective effect on microvascular morbidity has
been highlighted previously [25]. High levels of physical
activity are beneficial for individuals with type 2 diabetes as
it is linked with better glucose control [25]. Similar to the
present study, the Health and Retirement Study (HRS) in
the USA [34] reported that individuals with diabetes-related
microvascular complications were less likely to engage in
high levels of physical activity. Janevic et al. [34] suggest that
the development of diabetes-related complicationsmay cause
clinical, practical, and psychological barriers to engaging
in physical activity. Therefore, additional support may be
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needed to achieve the recommended amounts of physical
activity in those who have developed complications [34].
The major strength of this study is the large national
population-based sample and the high response rate (62%).
Inverse probability weights were calculated to take into
account the underrepresentation of individuals with lower
levels of education attainment and to adjust for the lower
response rate in age and sex groupings [20]. Study weights
were applied to all analyses to correct for differential nonre-
sponse. Therefore, selection bias was minimised and TILDA
sample is representative of the general Irish population [20].
However, several limitations need to be considered when
interpreting the findings. Firstly, data used in the analyses
were based on self-report and were not ascertained by an
objective method. Self-reporting is a recognised limitation
in all surveys due to potential inaccuracies and recall and
reporting bias [47]. When compared with medical records,
data based on self-report have been shown to underestimate
the prevalence of diabetic retinopathy [48] and heart failure
[49]. In the present study, the prevalence of complications
may have been underestimated; as a consequence the mea-
sure of association may be biased toward the null. However,
moderate-to-high levels of agreement, between self-report
and medical records, have been demonstrated for diabetes
[49, 50], myocardial infarction [49], stroke [49, 50], and
hypertension [49]. Data on smoking and physical activity
were also based on self-report where socially desirable
responses are a documented phenomenon [47].
Secondly, recall bias should be considered. Participants
who were recently diagnosed with diabetes may remember
the age of their diagnosis with greater precision. Incorrect
reporting may result in differential misclassification and
could lead to a subsequent decrease in the measure of
association if the number of years since diabetes diagno-
sis has been overestimated. Nevertheless, the previously
documented association between microvascular disease and
longer duration since diagnosis [12, 24–26, 33, 35] was
detected in this study. Finally, a cross-sectional study design
does not permit assessment of causality. For instance, it
is not possible to infer if a high level of physical activity
reduces the risk of microvascular complications or whether
the development of microvascular complications inhibits
physical activity [34].
5. Conclusions
Despite these limitations, findings from this study are in
accordancewith other research fromprospective cohort stud-
ies.We demonstrated that macrovascular complications were
more common in the male population and the probability
of microvascular complications was reduced in participants
with higher educational attainment. Additionally, modifiable
risk factors were independently associated with both macro-
and microvascular complications. While addressing lifestyle
factors is a key part of preventing complications, delivering
adequate services for people with diabetes is essential in ear-
lier detection and management of complications. In 2010, a
national diabetes programme was introduced in Ireland [51].
To date, the programme has been instrumental in the rollout
of a national retinal screening programme, the recruitment
of diabetes nurse specialists, and development of a national
foot care model [51]. Macrovascular and microvascular com-
plications are often preventable; therefore findings from this
study are useful for policy makers planning the development
of other diabetes services, including the diabetes cycle of care
that has been recently introduced into primary care in Ireland
[52]. Diabetes prevalence is projected to increase; therefore
effective prevention strategies are urgently needed to reduce
the future burden of complications in Ireland.
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